comparemela.com

Page 10 - Singapore Agency For Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Singaporean firm Mirxes enters Hong Kong to tap into growing multi-cancer early-stage screening market in Greater Bay Area

Mirxes, a spin-off of Singapore ’s Agency for Science, Technology and Research, expects China’s multi-cancer early-stage screening market to expandThe start-up’s move to Hong Kong followed its application in July for an IPO in the city’s stock exchange

Hong kongZhou lihanPrenetics groupSouth china morning postHorizon healthInternational agency for research on cancerSingapore agency for scienceMirxes holdingGreater bay areaSouth china morningInternational agencyHangzhou based new horizon healthCancer studies

Aptorum Group Receives Nasdaq Approval to Transfer Listing to Nasdaq Capital Markets

Aptorum Group Limited , a clinical-stage biopharmaceutical company, announced that it has received an approval letter from the Nasdaq Stock Market LLC Listing Qualifications Department notifying. -Today at 02:58 am- MarketScreener

Singapore agency for scienceAptorum group orAptorum group limited nasdaqDaptorum groupAptorum group formNasdaq stock marketNasdaq listing qualifications departmentAptorum group limitedListing qualifications departmentNasdaq global marketNasdaq capitalGroup limitedSecurities litigation reform act

Mirxes advances RNA technology to diminish the economic burden of cancer

The company is determined to scale globally to mitigate the increasing economic burden of cancer

Tan tock seng hospitalSingapore generalUnited statesRepublic ofThe philippinesEarly medical centreSingapore agency for scienceSingapore ministry of healthFortitude kitsSoutheast asiaCancer detected early can be curedElion medika indonesiaSequencing system

Singaporean firm Mirxes pushes into GBA s multi-cancer early screening market

Mirxes, a spin-off of Singapore ’s Agency for Science, Technology and Research, will establish a foothold in Hong Kong this year to tap into the vast…

Hong kongSingapore agency for scienceGreater bayReaking news

Biotech start-up Mirxes weighs Singapore IPO, aims to double global headcount by 2026

Mirxes is considering the possibility of a dual listing on SGX and HKEX. Read more at straitstimes.com.

Hong kongZhou lihanSingapore agency for scienceHorizon healthResearcha starSingapore exchangeVenture fundHong kong exchangesBusiness timesStraits timesBeijing fupuNorth asiaNew horizon healthNorth asian

vimarsana © 2020. All Rights Reserved.